• 1
    Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353: 48797.
  • 2
    Braam RL, Van Uum SH, Russel FG, Swinkels DW, Thien T. Bromide as a marker to measure adherence to drug therapy. Eur J Clin Pharmacol 2006; 62: 28590.
  • 3
    Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 6774.
  • 4
    Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone compliance to high blood pressure therapy scale. Prog Cardiovasc Nurs 2000; 15: 906.
  • 5
    Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. Is this patient taking the treatment as prescribed? JAMA 1993; 269: 277981.
  • 6
    Urquhart J. Role of patient compliance in clinical pharmacokinetics. A review of recent research. Clin Pharmacokinet 1994; 27: 20215.
  • 7
    Burnier M, Santschi V, Favrat B, Brunner HR. Monitoring compliance in resistant hypertension: an important step in patient management. J Hypertens 2003; 21 (Suppl. 2): S3742.
  • 8
    Baulmann J, Düsing R, Vetter H, Mengden Th. Therapy resistant hypertension – significance of electronic compliance monitoring. Dtsch Med Wochenschr 2002; 127: 237982.
  • 9
    Roth HP, Caron HS, Bartholomew P. Measuring intake of a prescribed medication, a bottle count and a tracer technique compared. Clin Pharmacol Ther 1970; 11: 22837.
  • 10
    Pullar T, Kumar S, Tindall H, Feely M. Time to stop counting the tablets? Clin Pharmacol Ther 1989; 46: 1638.
  • 11
    Mäenpää H, Javela K, Pikkarainen J, Mälkönen M, Heinonen OP, Manninen V. Minimal doses of digoxin: a new marker for compliance to medication. Eur Heart J 1987; 8 (Suppl.): 317.
  • 12
    Feely M, Cooke J, Price D, Singleton S, Mehta A, Bradford L, Carlvert R. Low-dose phenobarbitone as an indicator of compliance with drug therapy. Br J Clin Pharmacol 1987; 24: 7783.